1-naphthylamine has been researched along with Depression in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.25) | 18.7374 |
1990's | 30 (93.75) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fawcett, JA; Gelenberg, A; Harrison, W; Hirschfeld, RM; Keller, MB; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A | 1 |
Christenson, JL; Cushing, AG; Haider, A; Miller, DR; Station, RD | 1 |
Schleis, T | 1 |
Iruela, LM | 1 |
Berti, CA; Doogan, DP | 1 |
Jackson, CW; Lydiard, RB; Morton, WA | 1 |
Bandettini, FC; Bhatara, VS | 1 |
Olanow, CW | 1 |
Gammon, GD | 1 |
Lane, RM; Preskorn, SH | 1 |
Berti, C; Dinan, TG; Thakore, JH | 1 |
Fattinger, K; Kind, B; Krähenbühl, S; Meier-Abt, PJ | 1 |
Sprenger, D | 1 |
Meier, E; Sánchez, C | 1 |
Carson, WH; DeVane, CL; Gill, HS; Markowitz, JS | 1 |
Feeney, DJ; Klykylo, WM | 1 |
Noyer, CM; Schwartz, BM | 1 |
Brown, C; Endicott, J; Frank, E; Freeman, E; Halbreich, U; Harrison, W; Parry, B; Pearlstein, T; Severino, S; Stone, A; Stout, A; Yonkers, KA | 1 |
Hauser, RA; Zesiewicz, TA | 1 |
Bundren, JC; Morris, DW; Warnock, JK | 1 |
Bell, C; Nutt, DJ; Wilson, S | 1 |
Navarro, R; Spangler, M; Valler, WE | 1 |
Brown, RE; Hatziandreu, EJ; Levine, S; Martindale, J; Revicki, DA; Siegel, JE; Turner, R | 1 |
Edgell, ET; Hylan, TR; Sacristán, JA | 1 |
McTavish, D; Murdoch, D | 1 |
Curtis, AL; Valentino, RJ | 1 |
Guthrie, SK | 1 |
Butler, J; Leonard, BE | 1 |
Angrist, B; Floyd, A; Gershon, S; Park, S | 1 |
4 review(s) available for 1-naphthylamine and Depression
Article | Year |
---|---|
Sertraline 50 mg daily: the optimal dose in the treatment of depression.
Topics: 1-Naphthylamine; Depression; Dose-Response Relationship, Drug; Humans; Safety; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Binding Sites; Brain; Depression; Drug Tolerance; Electroencephalography; Humans; Obsessive-Compulsive Disorder; Psychomotor Performance; Rats; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1992 |
Pharmacology of locus coeruleus spontaneous and sensory-evoked activity.
Topics: 1-Naphthylamine; Action Potentials; Animals; Antidepressive Agents; Corticotropin-Releasing Hormone; Depression; Depression, Chemical; Desipramine; Drug Tolerance; Electroshock; Humans; Hypothalamo-Hypophyseal System; Locus Coeruleus; Mianserin; Nitroprusside; Pain; Rats; Sertraline; Stress, Physiological | 1991 |
Sertraline: a new specific serotonin reuptake blocker.
Topics: 1-Naphthylamine; Aged; Alcohol Drinking; Animals; Appetite; Clinical Trials as Topic; Depression; Down-Regulation; Drug Interactions; Humans; Middle Aged; Obsessive-Compulsive Disorder; Psychomotor Performance; Serotonin Antagonists; Sertraline | 1991 |
6 trial(s) available for 1-naphthylamine and Depression
Article | Year |
---|---|
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Depression; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Clinical effect of converting antidepressant therapy from fluoxetine to sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method | 1995 |
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Topics: 1-Naphthylamine; Adult; Analysis of Variance; Depression; Double-Blind Method; Efficiency; Female; Humans; Irritable Mood; Luteal Phase; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment | 1997 |
Sertraline for the treatment of depression in Parkinson's disease.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Parkinson Disease; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
[Chronic depression in the year 2000: therapeutic hopes. 10th World Congress for Psychiatry. Madrid, 24 August 1996].
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Depression; Humans; Placebos; Sertraline | 1996 |
Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.
Topics: 1-Naphthylamine; Adult; Affect; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Depression; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Psychiatric Status Rating Scales; Retrospective Studies; Sertraline | 1998 |
22 other study(ies) available for 1-naphthylamine and Depression
Article | Year |
---|---|
Realities of the fluoxetine-to-sertraline switch.
Topics: 1-Naphthylamine; Cost-Benefit Analysis; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Tablets | 1995 |
Sudden chest pain with sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Aspirin; Chest Pain; Coronary Disease; Depression; Humans; Male; Middle Aged; Nortriptyline; Propranolol; Sertraline | 1994 |
Sudden chest pain with sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Chest Pain; Depression; Electrocardiography; Heart; Humans; Male; Reference Values; Sertraline | 1994 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone | 1994 |
Possible interaction between sertraline and tranylcypromine.
Topics: 1-Naphthylamine; Clonazepam; Depression; Drug Administration Schedule; Drug Interactions; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Tranylcypromine | 1993 |
A 61-year-old man with Parkinson's disease.
Topics: 1-Naphthylamine; Antiparkinson Agents; Carbidopa; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Family Practice; Humans; Levodopa; Male; Middle Aged; Neurology; Neuroprotective Agents; Parkinson Disease; Selegiline; Sertraline; Vitamin E | 1996 |
Incentive bias?
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Costs; Drug Industry; Financial Support; Humans; Paroxetine; Prejudice; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
An open trial of adjunctive sertraline in the treatment of chronic schizophrenia.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Sertraline; Treatment Outcome | 1996 |
[The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Topics: 1-Naphthylamine; Antidepressive Agents; Antiemetics; Depression; Drug Interactions; Female; Humans; Ondansetron; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 1996 |
Sertraline for nocturnal enuresis.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depression; Enuresis; Humans; Male; Sertraline | 1997 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Awareness of potential drug interactions may aid avoidance.
Topics: 1-Naphthylamine; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depression; Drug Interactions; Humans; Male; Middle Aged; Mixed Function Oxygenases; Sertraline | 1997 |
Medication-induced seizures.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Depression; Drug Therapy, Combination; Humans; Male; Methylphenidate; Seizures; Sertraline | 1997 |
Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome.
Topics: 1-Naphthylamine; Carcinoid Tumor; Depression; Female; Humans; Liver Neoplasms; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
[Advances in depression therapy. Sertralin: highly selective SSRI with low interaction potential].
Topics: 1-Naphthylamine; Depression; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Pindolol augmentation of sertraline in resistant depression and its effect on sleep.
Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Brain; Depression; Drug Synergism; Electroencephalography; Female; Humans; Pindolol; Serotonin; Sertraline; Sleep | 1998 |
Antidepressant utilization in managed care: an evaluation of SSRI use in two HMO settings.
Topics: 1-Naphthylamine; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Drug Costs; Drug Utilization Review; Fluoxetine; Humans; Managed Care Programs; Models, Organizational; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; United States | 1995 |
Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin.
Topics: 1-Naphthylamine; Adult; Costs and Cost Analysis; Depression; Dothiepin; Female; Humans; Male; Models, Econometric; Quality of Life; Recurrence; Value of Life | 1994 |
Sertraline. A pharmacoeconomic evaluation of its use in depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Depression; Health Care Costs; Humans; Sertraline | 1997 |
If at first you do succeed.
Topics: 1-Naphthylamine; Antidepressive Agents; Benzamides; Depression; Fluoxetine; Half-Life; Humans; Moclobemide; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1991 |
The platelet serotonergic system in depression and following sertraline treatment.
Topics: 1-Naphthylamine; Blood Platelets; Depression; Female; Humans; Male; Naphthalenes; Platelet Aggregation; Radioligand Assay; Receptors, Serotonin; Serotonin; Sertraline | 1988 |
Evaluation of an aminotetraline, CP 14.368, as an antidepressant.
Topics: 1-Naphthylamine; Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antidepressive Agents; Depression; Electrocardiography; Evaluation Studies as Topic; Humans; Methylamines; Naphthalenes; Psychiatric Status Rating Scales | 1972 |